Literature DB >> 23901230

Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization.

Young-Joo Jin1, Jin-Woo Lee, Seoung-Wook Park, Jung Il Lee, Don Haeng Lee, Young Soo Kim, Soon Gu Cho, Yong Sun Jeon, Kun Young Lee, Seung-Ik Ahn.   

Abstract

AIM: To evaluate clinical outcomes of patients that underwent surgery, transarterial embolization (TAE), or supportive care for spontaneously ruptured hepatocellular carcinoma (HCC).
METHODS: A consecutive 54 patients who diagnosed as spontaneously ruptured HCC at our institution between 2003 and 2012 were retrospectively enrolled. HCC was diagnosed based on the diagnostic guidelines issued by the 2005 American Association for the Study of Liver Diseases. HCC rupture was defined as disruption of the peritumoral liver capsule with enhanced fluid collection in the perihepatic area adjacent to the HCC by dynamic liver computed tomography, and when abdominal paracentesis showed an ascitic red blood cell count of > 50000 mm(3)/mL in bloody fluid.
RESULTS: Of the 54 patients, 6 (11.1%) underwent surgery, 25 (46.3%) TAE, and 23 (42.6%) supportive care. The 2-, 4- and 6-mo cumulative survival rates at 2, 4 and 6 mo were significantly higher in the surgery (60%, 60% and 60%) or TAE (36%, 20% and 20%) groups than in the supportive care group (8.7%, 0% and 0%), respectively (each, P < 0.01), and tended to be higher in the surgical group than in the TAE group. Multivariate analysis showed that serum bilirubin (HR = 1.09, P < 0.01), creatinine (HR = 1.46, P = 0.04), and vasopressor requirement (HR = 2.37, P = 0.02) were significantly associated with post-treatment mortality, whereas surgery (HR = 0.41, P < 0.01), and TAE (HR = 0.13, P = 0.01) were inversely associated with post-treatment mortality.
CONCLUSION: Post-treatment survival after surgery or TAE was found to be better than after supportive care, and surgery tended to provide better survival benefit than TAE.

Entities:  

Keywords:  Ruptured hepatocellular carcinoma; Surgery; Transarterial embolization

Mesh:

Year:  2013        PMID: 23901230      PMCID: PMC3725379          DOI: 10.3748/wjg.v19.i28.4537

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation.

Authors:  Gisela C Mueller; Hero K Hussain; Ruth C Carlos; Hanh V Nghiem; Isaac R Francis
Journal:  AJR Am J Roentgenol       Date:  2003-03       Impact factor: 3.959

2.  A retrospective review of transcatheter hepatic arterial embolisation for ruptured hepatocellular carcinoma.

Authors:  C S Leung; C N Tang; K H Fung; M K W Li
Journal:  J R Coll Surg Edinb       Date:  2002-10

Review 3.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

Review 4.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 5.  Hepatocellular carcinoma: recent trends in the United States.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 7.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

8.  Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey.

Authors:  Taku Aoki; Norihiro Kokudo; Yutaka Matsuyama; Namiki Izumi; Takafumi Ichida; Masatoshi Kudo; Yonson Ku; Michiie Sakamoto; Osamu Nakashima; Osamu Matsui; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

9.  Emergency embolization of spontaneous ruptured hepatocellular carcinoma: correlation between survival and Child-Pugh classification.

Authors:  K Y Lau; T P Wong; W W C Wong; L T H Tan; J K W Chan; A S L Lee
Journal:  Australas Radiol       Date:  2003-09

Review 10.  Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure.

Authors:  Stephen M Riordan; Roger Williams
Journal:  Semin Liver Dis       Date:  2003-08       Impact factor: 6.115

View more
  21 in total

Review 1.  Update on Embolization Therapies for Hepatocellular Carcinoma.

Authors:  Sirish Kishore; Tamir Friedman; David C Madoff
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

Review 2.  Rupture of Hepatocellular Carcinoma: A Review of Literature.

Authors:  Srimanta K Sahu; Yogesh K Chawla; Radha K Dhiman; Virendra Singh; Ajay Duseja; Sunil Taneja; Naveen Kalra; Ujjwal Gorsi
Journal:  J Clin Exp Hepatol       Date:  2018-04-26

3.  Prognostic factors of spontaneously ruptured hepatocellular carcinoma.

Authors:  Xiang-Jun Han; Hong-Ying Su; Hai-Bo Shao; Ke Xu
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

4.  Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma.

Authors:  Jixue Zou; Jia Yuan; Hong Chen; Xinghao Zhou; Tongchun Xue; Rongxin Chen; Lan Zhang; Zhenggang Ren
Journal:  J Gastrointest Oncol       Date:  2022-06

5.  Survival of Patients Subjected to Hepatectomy After Spontaneous Rupture of Hepatocellular Carcinoma: A Meta-analysis of High-quality Propensity Score Matching Studies.

Authors:  Xiaozhun Huang; Chenyang Jia; Lin Xu; Xinyu Bi; Fengyong Lai; Zhangkan Huang; Xiaoqing Li; Xin Yin; Yong Ni; Xu Che
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

6.  Gelatin sponge microparticles for the treatment of the spontaneous rupture of hepatocellular carcinoma hemorrhage.

Authors:  Pu Zhao Wu; Jun Zhou; Yue Wei Zhang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

7.  Huge hepatocellular carcinoma with multiple intrahepatic metastases: An aggressive multimodal treatment.

Authors:  Satoshi Yasuda; Takeo Nomi; Daisuke Hokuto; Ichiro Yamato; Shinsaku Obara; Takatsugu Yamada; Hiromichi Kanehiro; Yoshiyuki Nakajima
Journal:  Int J Surg Case Rep       Date:  2015-09-18

8.  Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study.

Authors:  Hanteng Yang; Kefei Chen; Yongang Wei; Fei Liu; Hongyu Li; Zhipeng Zhou; Bo Li
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

9.  Damage Control Surgery for Hepatocellular Cancer Rupture in an Elderly Patient: Survival and Quality of Life.

Authors:  Konstantinos Bouliaris; Grigorios Christodoulidis; Dimitrios Symeonidis; Alexandros Diamantis; Konstantinos Tepetes
Journal:  Case Rep Emerg Med       Date:  2015-10-04

10.  Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinoma.

Authors:  Wen-Hui Chan; Chien-Fu Hung; Kuang-Tse Pan; Kar-Wai Lui; Yu-Ting Huang; Shen-Yen Lin; Yang-Yu Lin; Tsung-Han Wu; Ming-Chin Yu
Journal:  J Surg Oncol       Date:  2016-04-07       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.